Oncology Programs:


Next generation oncolytics for solid tumors

Oncolytics have the potential to improve outcomes in oncology patients without incurring the severe side effects of radiation and chemotherapy. Other oncolytic viruses in clinical development to date have not been shown toprevent or treat metastases. The Codagenix oncolytic has the potential to shrink primary solid tumors and prevent metastases, without the need for vaccination prior to treatment.